Proseguendo nell’intervista, afferma che il settore delle aziende farmaceutiche ha sempre cercato di innovare, ma questo modello, dice, probabilmente infastidisce. Bisognerebbe conoscere meglio il settore, lasciare da parte i pregiudizi e parlare con cognizione di causa.
To the accusations that Farmindustria is a lobby interested only in the sale of medicines, he replies that these too are prejudices. He cites, for example, the case of vaccines in which 40 are saved for every euro spent on them and, he says, it is certainly not true that they are needed to sell more
The drug, continues Scaccabarozzi, can be good or bad: it is good when necessary and prescribed by a doctor.
He then concludes, speaking of untraceable medicines, that the cost of medicines in Italy is 30%/40% lower than in other European countries. Due to the free movement of goods in Europe, some distributors buy at Italian prices to resell at European prices. He observes that the price of medicines in Italy is negotiated with AIFA for the NHS and cannot be valid for everyone. AIFA and the Ministry are looking for a solution
Summary by the Fedaiisf editorial staff. Article about Doctor33 – 09/03/2016 “Industria farmaceutica, Scaccabarozzi: troppi pregiudizi. Il nostro modello gestionale vincente”